The U.S. regulator closed its investigation into “Ethereum 2.0,” Consensys said.Policy, news, SEC, US, Regulation, Policy, ConsenSys, Ethereum 2.0, ethererumRead More

You might also be interested in reading Bluejay Therapeutics Announces First Patient Dosed in AZURE-1 Global Pivotal Clinical Trial Evaluating Brelovitug (BJT-778) as a Monotherapy Treatment for Chronic Hepatitis D.